Integration of neuro-endocrine immune responses in defense of mucosal surfaces

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 4 SUPPL., 1999, Pages 26-34

  Befus, A Dean ^a   Mathison, Ron ^b   Davison, Joe ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; IMMUNOSTIMULATION; NEUROENDOCRINOLOGY; SIGNAL TRANSDUCTION;

EID: 0032953124     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.26     Document Type: Conference Paper

References (94)

1. Ader R, Cohen N, 1993. Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol 44: 53-85.
2. Berczi I, Baragar FD, Chalmers IM, Keystone EC, Nagy E, Warrington RJ, 1993. Hormones in self tolerance and auto-immunity: a role in the pathogenesis of rheumatoid arthritis. Autoimmunity 16: 45-56.
3. Reichlin S, 1993. Neuroendocrine-immune interactions. N Engl J Med 329: 1246-1253.
4. Blalock JE, 1994. The immune system: our sixth sense. Immunologist 2: 8-15.
5. Mathison R, Davison JS, Befus AD, 1994. Neuroendocrine regulation of inflammation and tissue repair by submandibular gland factors. Immunol Today 15: 527-532.
6. Ottaway CA, Husband AJ, 1994. The influence of neuroendocrine pathways on lymphocyte migration. Immunol Today 15: 511-517.
7. Sheridan JF, Dobbs C, Brown D, Zwilling B, 1994. Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection. Clin Microbiol Rev 7: 200-212.
8. Savino W, Dardenne M, 1995. Immune-neuroendocrine interactions. Immunol Today 16: 318-321.
9. Wilder RL, 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13: 307-338.
10. Williams RM, Bienenstock J, Stead RH, 1995. Mast cells: the neuroimmune connection. Marone G, ed. Human Basophils and Mast Cells: Biological Aspects. Basel: Karger, 208-235.
11. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S, 1985. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135: 755s-765s.
12. Dvorak AM, Osage JE, Monahan RA, Dickersin GR, 1980. Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Human Pathol 11: 620-634.
13. Stead RH, Kosecka-Janiszewska U, Oestreicher AB, Dixon NIF, Bienenstock J, 1991. Remodeling of B-50 (GAP-43)-and NSE-immunoreactive mucosal nerves in the intestines of rats infected with Nippostrongvlus brasiliensis. J Neurosci 11: 3809-3821.
14. Ader R, Cohen N, 1975. Behaviorally conditioned immunosuppression. Psychosom Med 37: 333-340.
15. Ader R, Cohen N, 1982. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215: 1534-1536.
16. Dyck DG, Greenberg AH, Osachuk T, 1986. Tolerance to drug-induced (Poly I:C) natural killer (NK) cell activation: congruence with a Pavlovian conditioning model. J Exp Psychol Anim Behav Process 4: 93-104.
17. Gorczynski RM, Macrae S, Kennedy M, 1982. Conditioned immune response associated with allogeneic skin grafts in mice. J Immunol 129: 704-709.
18. Grochowicz P, Schedlowski M, Husband AJ, King MG, Hibberd AD, Bowen KM, 1991. Behavioral conditioning prolongs heart allograft survival in rats. Brain Behav Immun 5: 349-356.
19. Lysle DT, Luecken LJ, Maslonek KA, 1992. Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus. Brain Behav Immun 6: 64-73.
20. Gorczynski RM, Kennedy M, Ciampi A, 1985. Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression. J Immunol 134: 4261-4266.
21. Lysle DT, Luecken LJ, Maslonek KA, 1992. Modulation of immune function by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids. Brain Behav Immun 6: 179-188.
22. Hermann GE, O'Dorisio MS, 1991. Modulation of IgA synthesis by neuroendocrine peptides. Trends Endocrinol Metab 2: 68-72.
23. Johnson HM, Downs MO, Pontzer CH, 1992. Neuroendocrine peptide hormone regulation of immunity. Blalock JE, ed. Neuroimmunoendocrinology. Basel: Karger, 49-83.
24. Carr DJJ, 1992. Neuroendocrine peptide receptors on cells of the immune system. Blalock JE, ed. Neuroimmunoendocrinology. Basel: Karger, 84-105.
25. Benveniste EN, 1992. Cytokines: influence on glial cell gene expression and function. Blalock JE, ed. Neuroimmunoendocrinology. Basel: Karger, 106-153.
26. Smith EM, 1992. Hormonal activities of cytokines. Blalock JE, ed. Neuroimmunoendocrinology. Basel: Karger, 154-169.
27. Owens T, Renno T, Taupin V, Krakowski M, 1994. Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunol Today 15: 566-571.
28. Besedovsky H, Del Rey A, Sorkin E, Da Prada M, Burri R, Honegger C, 1983. The immune response evokes changes in brain noradrenergic neurons. Science 221: 564-566.
29. Besedovsky H, Sorkin E, Felix D, Haas H, 1977. Hypothalamic changes during the immune response. Ear J Immunol 7: 323-325.
30. Oldstone MA, 1983. Immunopathology of persistent viral infection. Dixon FJ, Fisher DW, eds. The Biology of Immunologic Disease. Sunderland, MA: Sinauer Associates, Inc., 283-294.
31. Fabry Z, Raine CS, Hart MN, 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 15: 218-224.
32. Miller SD, Karpus WJ, 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 15: 356-361.
33. Nottet HSLM, Gendelman HE, 1995, Unraveling the neuroimmune mechanisms for the HIV-I-associated cognitive/motor complex. Immunol Today 16: 441-448.
34. Collins SM, Blennerhassett PA, Blennerhassett MG, Vermillion DL, 1989. Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol 257: G898-G903.
35. Swain MG, Blennerhassett PA, Collins SM, 1991. Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology 100: 675-682.
36. Fernandez A, Hontebeyrie M, Said G, 1992. Autonomic neuropathy and immunological abnormalities in Chagas' disease. Clin Autom Res 2: 409-412.
37. Wick G, Hu Y, Gruber J, 1992. The role of immunoendocrine interaction via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Trends Endocrinol Metab 3: 141-146.
38. Sternbert EM, Young WS III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL, 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 86: 4771-4775.
39. Edwards CKI, Yunger LM, Lorence RM, Dantzer R, Kelley KW, 1991. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci USA 88: 2274-2277.
40. Pernow B, 1985. Role of tachykinins in neurogenic inflammation. J Immunol 135: 812s-815s.
41. Brokaw JJ, McDonald DM, 1988. Neurally mediated increase in vascular permeability in the rat trachea: onset, duration, and tachyphylaxis. Exp Lung Res 14: 757-767.
42. Barnes PJ, Belvisi MG, Rogers DR 1990. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmaceut Sci 11: 185-189.
43. Bevan S, Szolcsanyi J, 1990. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmaceut Sd 11: 330-333.
44. Baraniuk JN, Kowalski NEL, Kaliner MA, 1990. Relationships between permeable vessels, nerves, and mast cells in rat cutaneous neurogenic inflammation. J Appl Physiol 68: 2305-2311.
45. Kowalski ML, Sliwinska-Kowalska M, Kaliner MA, 1990. Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation. J Immunol 145: 1214-1221.
46. Foreman JC, 1993. Non-immunological stimuli of mast cells and basophil leucocytes. Foreman JC, ed. The Handbook of Immunopharmacology. London: Academic Press Harcourt Brace and Company, 57-69.
47. Germonpre PR, Joos GF, Everaert E, Kips JC, Pauwels RA, 1995. Characterization of neurogenic inflammation in the airways of two highly inbred rat strains. Am J Respir Crit Care Med 152: 1796-1804.
48. McDonald DM, 1988. Respiratory tract infections increase susceptibility to neurogenic inflammation in the rat trachea. Am Rev Respir Dis 137: 1432-1440.
49. Borson DB, Sekizawa K, McDonald DM, Nadel JA, 1989. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 66: 2653-2658.
50. Umeno E, Nadel JA, Huang H, McDonald DM, 1989. Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat trachea. J Appl Physiol 66: 2647-2652.
51. Swain MG, Agro A, Blennerhassett P, Stanisz A, Collins SM, 1992. Increased levels of substance P in the myenteric plexus of Trichinella-infected rats. Gastroenterology 102: 1913-1919.
52. Hwang L, Leichter R, Okamoto A, Pavan D, Collins SM, Bunnett NW, 1993. Downregulation of neutral endopeptidase (ED 3.4.24.11) in the inflamed rat intestine. Am J Physiol 264: G737-G743.
53. Mathison R, Davison JS, 1995. Regulation of jejunal arterioles by capsaicin-sensitive nerves in Nippostrongylus brasiliensissensitized rats. J Pharmacol Exp Ther 273: 337-343.
54. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J, 1987. Intestinal mucosal mast cells in normal and nematode-infecled rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 84: 2975-2979.
55. Arizono N, Matsuda S, Hattori T, Kojima Y, Maeda T, Galli SJ, 1990. Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin. Lab Invest 62: 626-634.
56. Blennerhassett MG, Tomioka M, Bienenstock J, 1991. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res 265: 121-128.
57. Blennerhassett MG, Bienenstock J, 1990. Apparent innervation of rat basophilic leukaemia (RBL-2H3) cells by sympathetic nerves in vitro. Neurosci Lett 120: 50-54.
58. Woodbury RG, Miller HR, Huntley JF, Newlands GF, Palliser AC, Wakelin D, 1984. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature 312: 450-452.
59. Sharkey KA, Coggins PJ, Tetzlaff W, Zwiers H, Bisby MA, Davison JS, 1990. Distribution of growth-associated protein, B-50 (GAP-43) in the mammalian enteric nervous system. Neuroscience 38: 13-20.
60. Johnson AR, Erdos EG, 1973. Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med 142: 1252-1256.
61. Shanahan F, Denburg J, Fox J, Bienenstock J, Befus D, 1985. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135: 1331-1337.
62. Benyon RC, 1988. Stimulus-secretion coupling in mast cells and basophils. Holgate ST, ed. Mast Cells, Mediators and Disease. Dordrecht: Kluwer Academic Publishers, 195-227.
63. Janiszewski J, Bienenstock J, Blennerhassett MG, 1994. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 267: C138-C145.
64. Barnes PJ, 1995. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 152: 838-860.
65. White SR, Stimler-Gerard NP, Munoz NM, Popovich KJ, Murphy TM, Blake JS, Mack MM, Leff AR, 1989. Effect of betaadrenergic blockade and sympathetic stimulation on canine bronchial mast cell response to immune degranulation in vivo. Am Rev Respir Dis 139: 73-79.
66. Bissonnette EY, Befus AD, 1997. Anti-inflammatory effect of β2 agonists: inhibition of TNF-α release from human mast cells. J Allergy Clin Immunol 100: 825-831.
67. Goetzl EJ, Chernov T, Renold F, Payan DG, 1985. Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135: 802s-805s.
68. Undem BJ, Riccio MM, Weinreich D, Ellis JL, Myers AC, 1995. Neurophysiology of mast cell-nerve interactions in the airways. Int Arch Allergy Immunol 107: 199-201.
69. Greene R, Fowler J, MacGlashan Jr D, Weinreich D, 1988. IgE-challenged human lung mast cells excile vagal sensory neurons in vitro. J Appl Physiol 64: 2249-2253.
70. Tam EK, 1995. Mast cell neuropeptidases. Caughey GH, ed. Mast Cell Proteases in Immunology and Biology. New York: Marcel Dekker, Inc., 71-107.
71. Tam EK, Gaughey GH, 1990. Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 3: 27-32.
72. Brain SD, Williams TJ, 1988. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335: 73-75.
73. Russell M, Dark KA, Cummins RW, Ellman G, Callawy E, Peeke HVS, 1984. Learned histamine release. Science 225: 733-734.
74. MacQueen G, Marshall J, Perdue M, Siegel S, Blenenstock J, 1989. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 243: 83-85.
75. Gauci M, Husband AJ, Saxarra H, King MG, 1994. Pavlovian conditioning of nasal tryptase release in human subjects with allergic rhinitis. Physiol Behav 55: 823-825.
76. Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O'Keane JC, Jaffer A, Theoharides TC, Pothoulakis C, 1994. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107: 657-665.
77. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider RM, Leeman SE, 1994. CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci USA 91: 947-951.
78. Kurose I, Pothoulakis C, LaMont JT, Anderson DC, Paulson JC, Miyasaka M, Wolf R, Granger DN, 1994. Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. J Clin Invest 94: 1919-1926.
79. Weinstock JV, 1992. The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: interactions between the schistosome ova and the host. Immunol Invest 21: 455-475.
80. Weinstock JV, Blum A, Walder J, Walder R, 1988. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 141: 961-966.
81. Weinstock JV, Blum AM, 1989. Tachykinin production in granulomas of murine schistosomiasis mansoni. J Immunol 142: 3256-3261.
82. Mathew RC, Cook GA, Blum AM, Metwall A, Felman R, Weinstock JV, 1992. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection. J Immunol 148: 3572-3577.
83. Blum AM, Metwali A, Cook G, Mathew RC, Elliott D, Weinstock JV, 1993. Substance P modulates antigen-induced, IFN-gamma production in murine schistosomiasis mansoni. J Immunol 151: 225-233.
84. Cook GA, Elliott D, Metwali A, Blum AM, Sandor M, Lynch R, Weinstock JV, 1994. Molecular evidence of granuloma T lymphocytes in murine schistosomiasis mansoni express in authentic substance P (NK-1) receptor. J Immunol 152: 1830-1835.
85. Elliott DE, Metwall A, Blum AM, Sandor M, Lynch R, Weinstock JV, 1994. T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA. J Immunol 153: 1180-1186.
86. Blum AM, Metwali A, Mathew RC, Elliott D, Weinstock JV, 1993. Substance P and somatostatin can modulate the amount of IgG2a secreted in response to schistosome egg antigens in murine schistosomiasis mansoni. J Immunol 151: 6994-7004.
87. Ramaswamy K, Mathison R, Carter L, Kirk D, Green F, Davison JS, Befus D, 1990. Marked anti-inflammatory effects of decentralization of the superior cervical ganglia. J Exp Med 172: 1819-1830.
88. Carter L, Ferrari JK, Davison JS, Befus D, 1992. Inhibition of neutrophil chemotaxis and activation following decentralization of the superior cervical ganglia. J Leukoc Biol 51: 597-602.
89. Mathison R, Carter L, Mowat C, Bissonnette E, Davison JS, Befus AD, 1994. Temporal analysis of the anti-inflammatory effects of decentralization of the rat superior cervical ganglia. Am J Physiol 266: R1537-R1543.
90. Mathison R, Hogan A, Helmer D, Bauce L, Woolner J, Davison JS, Schultz G, Befus D, 1992. Role for the submandibular gland in modulating pulmonary inflammation following induction of systemic anaphylaxis. Brain Behav Immun 6: 117-129.
91. Bissonnette EY, Mathison R, Carter L, Davison JS, Befus AD, 1993. Decentralization of the superior cervical ganglia inhibits mast cell mediated TNF-alpha dependent cytotoxicity. 1. Potential role of salivary glands. Brain Behav Immun 7: 293-300.
92. Mathison R, Befus D, Davison JS, 1993. Removal of the submandibular glands increases the acute hypotensive response to endotoxin. Circ Shock 39: 52-58.
93. Mathison R, Befus AD, Davison JS, 1997. A novel submandibular gland peptide protects against endotoxic and anaphylactic shock. Am J Physiol 273: R1017-R1023.
94. Mathison R, Tan D, Oliver M, Befus D, Scott B, Davison JS, 1997. Submandibular gland peptide-T (SGP-T) inhibits intestinal anaphylaxis. Dig Dis Sci 42: 2378-2383.